374 related articles for article (PubMed ID: 9310393)
1. Differential effects on delayed non-matching-to-position in rats of microinjections of muscarinic receptor antagonist scopolamine or NMDA receptor antagonist MK-801 into the dorsal or ventral extent of the hippocampus.
Robinson JK; Mao JB
Brain Res; 1997 Aug; 765(1):51-60. PubMed ID: 9310393
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory avoidance memory deficit induced by scopolamine: Interaction of cholinergic and glutamatergic systems in the ventral tegmental area.
Mahmoodi G; Ahmadi S; Pourmotabbed A; Oryan S; Zarrindast MR
Neurobiol Learn Mem; 2010 Jul; 94(1):83-90. PubMed ID: 20403448
[TBL] [Abstract][Full Text] [Related]
3. Spatial signal detection in rats is differentially disrupted by delta-9-tetrahydrocannabinol, scopolamine, and MK-801.
Presburger G; Robinson JK
Behav Brain Res; 1999 Feb; 99(1):27-34. PubMed ID: 10512569
[TBL] [Abstract][Full Text] [Related]
4. Blockade of NMDA receptors located at the dorsomedial prefrontal cortex impairs spatial working memory in rats.
Aura J; Riekkinen P
Neuroreport; 1999 Feb; 10(2):243-8. PubMed ID: 10203316
[TBL] [Abstract][Full Text] [Related]
5. Acute treatment with the N-methyl-D-aspartate receptor antagonist MK-801: effect of concurrent administration of haloperidol or scopolamine on preproenkephalin mRNA levels of the striatum and nucleus accumbens of the rat brain.
Noailles PA; Villegas M; Ledoux M; Lucas LR; McEwen BS; Angulo JA
Neurosci Lett; 1996 Jan; 202(3):165-68. PubMed ID: 8848257
[TBL] [Abstract][Full Text] [Related]
6. Differential expression of NMDA and AMPA receptor subunits in rat dorsal and ventral hippocampus.
Pandis C; Sotiriou E; Kouvaras E; Asprodini E; Papatheodoropoulos C; Angelatou F
Neuroscience; 2006 Jun; 140(1):163-75. PubMed ID: 16542781
[TBL] [Abstract][Full Text] [Related]
7. The NMDA antagonist EAA 494 does not impair working memory in an operant DNMTP task in rats.
Ballard TM; Mcallister KH
Pharmacol Biochem Behav; 2000 Apr; 65(4):725-30. PubMed ID: 10764929
[TBL] [Abstract][Full Text] [Related]
8. Dorsal hippocampal muscarinic acetylcholine and NMDA receptors disrupt water maze navigation.
Riekkinen M; Riekkinen P
Neuroreport; 1997 Feb; 8(3):645-8. PubMed ID: 9106739
[TBL] [Abstract][Full Text] [Related]
9. Interaction between M1-muscarinic and glutamatergic NMDA receptors on an inhibitory avoidance task.
Monteiro Moreira K; Lima Ferreira T; Vecchio Fornari R; Perez Figueredo LZ; Menezes Oliveira MG
Brain Res Bull; 2005 Nov; 67(6):504-8. PubMed ID: 16216700
[TBL] [Abstract][Full Text] [Related]
10. WAY 100635, a 5-HT1A receptor antagonist, prevents the impairment of spatial learning caused by intrahippocampal administration of scopolamine or 7-chloro-kynurenic acid.
Carli M; Bonalumi P; Samanin R
Brain Res; 1997 Nov; 774(1-2):167-74. PubMed ID: 9452205
[TBL] [Abstract][Full Text] [Related]
11. Dorsal hippocampus and classical fear conditioning to tone and context in rats: effects of local NMDA-receptor blockade and stimulation.
Bast T; Zhang WN; Feldon J
Hippocampus; 2003; 13(6):657-75. PubMed ID: 12962312
[TBL] [Abstract][Full Text] [Related]
12. Dissociation between cognitive and motor/motivational deficits in the delayed matching to position test: effects of scopolamine, 8-OH-DPAT and EAA antagonists.
Stanhope KJ; McLenachan AP; Dourish CT
Psychopharmacology (Berl); 1995 Dec; 122(3):268-80. PubMed ID: 8748396
[TBL] [Abstract][Full Text] [Related]
13. Effects of ventral hippocampal galanin on spatial learning and on in vivo acetylcholine release in the rat.
Ogren SO; Kehr J; Schött PA
Neuroscience; 1996 Dec; 75(4):1127-40. PubMed ID: 8938746
[TBL] [Abstract][Full Text] [Related]
14. Reduction of dizocilpine and scopolamine-induced deficits in avoidance responding by SCH 54388, a metabolite of felbamate.
Smith RD; Grzelak ME; Coffin VL
Pharmacol Biochem Behav; 1997 Nov; 58(3):657-64. PubMed ID: 9329055
[TBL] [Abstract][Full Text] [Related]
15. Actions of NMDA and cholinergic receptor antagonists in the rostral ventromedial medulla upon beta-endorphin analgesia elicited from the ventrolateral periaqueductal gray.
Spinella M; Znamensky V; Moroz M; Ragnauth A; Bodnar RJ
Brain Res; 1999 May; 829(1-2):151-9. PubMed ID: 10350541
[TBL] [Abstract][Full Text] [Related]
16. A performance-dependent adjustment of the retention interval in a delayed non-matching-to-position paradigm differentiates effects of amnestic drugs in rats.
Han CJ; Pierre-Louis J; Scheff A; Robinson JK
Eur J Pharmacol; 2000 Sep; 403(1-2):87-93. PubMed ID: 10969148
[TBL] [Abstract][Full Text] [Related]
17. The effect of hippocampal NMDA receptor blockade by MK-801 on cued fear extinction.
Zhang B; Li CY; Wang XS
Behav Brain Res; 2017 Aug; 332():200-203. PubMed ID: 28578988
[TBL] [Abstract][Full Text] [Related]
18. Cognitive impairment following traumatic brain injury: the effect of pre- and post-injury administration of scopolamine and MK-801.
Hamm RJ; O'Dell DM; Pike BR; Lyeth BG
Brain Res Cogn Brain Res; 1993 Dec; 1(4):223-6. PubMed ID: 8003921
[TBL] [Abstract][Full Text] [Related]
19. Microinjection of GABA-A agonist muscimol into the dorsal but not the ventral hippocampus impairs non-mnemonic measures of delayed non-matching-to-position performance in rats.
Mao JB; Robinson JK
Brain Res; 1998 Feb; 784(1-2):139-47. PubMed ID: 9518581
[TBL] [Abstract][Full Text] [Related]
20. MK-801-induced and scopolamine-induced hyperactivity in rats neonatally treated chronically with MK-801.
Furuie H; Yamada K; Ichitani Y
Behav Pharmacol; 2013 Dec; 24(8):678-83. PubMed ID: 24113081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
